Do Not Tube List for Pharmaceuticals (Revised April 2021) 1=Drug Alteration 2=Expense 3=Flammable 4= Product Foaming 5=Short Exp/Admin Time 6=ok to tube powder, but not the reconstituted product 7=Aerosol Containers over 2.5 ounces in volume 8=hazardous, antineoplastic 9=hazardous, non-antineoplastic, liquid and parenteral dosage forms (ok to tube solids) Generic Drug Name Brand Name(s) Comments A B Abacavir Epzicom, Triumeq, Trizivir, Ziagen 9 Abatacept Orencia 1, 6 Abciximab ReoPro 1 Abemaciclib Verzenio 8 Abiraterone Yonsa, Zytiga 8 Acalabrutinib Calquence 8 Adalimumab Humira 2 Ado-trastuzumab Kadcyla 2, 8 Afatinib Gilotrif 8 Agalsidase beta Fabrazyme 1, 2 Albumin Albumin 1 Aldesleukin Interleukin-2, Proleukin 1, 2 Alectinib Alecensa 8 Alefacept Amevive 1, 2 Alemtuzumab Campath. Lemtrada 1 Alglucosidase alfa Myozyme 1, 6 Alpelisib Piqray 8 Alteplase, catheter clearance Cathflo 1, 6 Alteplase, treatment Activase 1, 2 Altretamine Hexalen 8 Aminolevulinic Acid Gleolan 2 Amsacrine AMSA PD 8 Amyl Nitrite inhalant Amyl Nitrite 3 Anakinra Kineret 1 Anastrozole Arimidex 8 Angiotensin II Giapreza 2 Anti-inhibitor coagulant complex Autoplex T, Feiba VH Immuno 5 Antithrombin Atryn 1, 6 Antithrombin III Thrombate 1, 6 Antithymocyte globulin Atgam, Thymoglobulin 1 Antivenin crotalidae (from equine) CroFab 2 Apalutamide Erleada 8 Aprepitant Cinvanti 1, 4 Aripiprazole (injection) Abilify Maintena 2 Arsenic trioxide Trisenox 8 Avapritinib Ayvakit 8 Avelumab Bavencio 1 Axitinib Inlyta 8 AzaCITIDine Vidaza 8 AzaTHIOprine Imuran 9 Bacillus calmette-geurin (bcg) Tice BCG, TheraCys 1 Approved by Pharmacy, Therapeutics, and Diagnostics Committee Reference: Safety SOP - Pneumatic Tube System Do Not Tube List for Pharmaceuticals (Revised April 2021) 1=Drug Alteration 2=Expense 3=Flammable 4= Product Foaming 5=Short Exp/Admin Time 6=ok to tube powder, but not the reconstituted product 7=Aerosol Containers over 2.5 ounces in volume 8=hazardous, antineoplastic 9=hazardous, non-antineoplastic, liquid and parenteral dosage forms (ok to tube solids) Generic Drug Name Brand Name(s) Comments Basiliximab Simulect 1, 2 BCG vaccine Theracys; Tice Vaccine 8 Belantamab mafodotin-blmf Blenrep 2, 8 Belinostat Beleodaq 8 Bendamustine Belrapzo, Bendeka, Treanda 2, 8 Benralizumab Fasenra 1 Benzocaine/tetracaine/butamben Cetacaine 7 Beractant Survanta 1 Bevacizumab Avastin, Mvasi 1, 2 Bexarotene Targretin 8 Bicalutamide Casodex 8 Bimatoprost Durysta 2 Binimetinib Mektovi 8 Bivalirudin Angiomax 1, 6 Bleomycin Blenoxane 8 Blood factor products All Blood Factor Products 1, 2 Bortezomib Velcade 2, 8 Bosutinib Bosulif 8 Botulinum toxin-A Botox 1, 6 Botulinum toxin-B Myobloc 1 Brentuximab vedotin Adcetris 8 Brexucabtagene autoleucel Tecartus 2 Brigatinib Alunbrig 8 Burosumab-twza Crysvita 1, 2 Busulfan injection Busulfex, Myleran 2, 8 C D C1 esterase inhibitor Berinert, Cinryze, Haegarda 1, 2 Cabazitaxel Jevtana 2, 8 Cabozantinib Cabometyx; Cometriq 8 Calfactant Infasurf 1 Capecitabine Xeloda 8 Caplacizumab Cablivi 1, 2 Capmatinib Tabrecta 8 CarBAMazepine Tegretol 9 CARBOplatin Paraplatin 8 Carfilzomib Kyprolis 8 Carmustine BiCNU, Gliadel 2, 8 Caspofungin Cancidas 4, 6 Cemiplimab-rwlc Libtayo 1, 2 Ceritinib Zykadia 8 Certolizumab pegol Cimzia 1, 2 Cetrorelix Cetrotide 9 Approved by Pharmacy, Therapeutics, and Diagnostics Committee Reference: Safety SOP - Pneumatic Tube System Do Not Tube List for Pharmaceuticals (Revised April 2021) 1=Drug Alteration 2=Expense 3=Flammable 4= Product Foaming 5=Short Exp/Admin Time 6=ok to tube powder, but not the reconstituted product 7=Aerosol Containers over 2.5 ounces in volume 8=hazardous, antineoplastic 9=hazardous, non-antineoplastic, liquid and parenteral dosage forms (ok to tube solids) Generic Drug Name Brand Name(s) Comments Cetuximab Erbitux 1 Chlorambucil Leukeran 8 Chloramphenicol Chloromycetin 9 Choriogonadotropin Ovidrel 9 Chorionic gonadotropin Novarel, Pregnyl, Profasi 1 Cidofovir Vistide 9 CISplatin Platinol-AQ 8 Cladribine Leustatin; 2-CDA 8 Clofarabine Clolar 2, 8 Cobimetinib Cotellic 8 Colchicine Gloperba 9 Colistimethate Coly-Mycin M 4, 6 Collagenase clostridium histolyticum Xiaflex 2 CONTROLLED SUBSTANCES SCHEDULE CII - CV Security Corticotropin Acthar Gel, H.P. 2 Crizanlizumab Adakveo 1, 2 Crizotinib Xalkori 8 Crotalidae polyvalent immune fab (ovine) Crofab 2 Cyclophosphamide Cytoxan 2, 8 cycloSPORINE Gengraf, Neoral, Sandimmune 9 Cytarabine liposomal DepoCyt, Vyxeos 2, 8 Cytomegalovirus immune globulin CytoGam 1, 4 Dabrafenib Tafinlar 8 Dacarbazine DTIC 8 Dacomitinib Vizimpro 8 DACTINomycin Cosmegen 8 DAPTOmycin Cubicin 1, 4, 6 Daratumumab / Hyaluronidase-fihj Darzalex Faspo 1, 2, 8 Darbepoetin alfa Aranesp 1, 2 Darolutamide Nubeqa 8 Dasatinib Sprycel 8 DAUNOrubicin Cerubidine, Daunomycin 8 DAUNOrubicin, liposomal Daunoxome, Vyxeos 8 Decitabine Dacogen 2, 8 Degarelix Firmagon 8 Denosumab Prolia, Xgeva 2 Dexamethasone intravitreal implant Ozurdex 2 Dexrazoxane Zinecard; Totect 9 Digitalis fab antibody Digibind, DigiFab 1, 2 Dihydroergotamine D.H.E. 45, Migranal 9 Dinoprostone vaginal suppository Prostin E2 2 DOCEtaxel Taxotere 8 Dornase alfa Pulmozyme 1 Approved by Pharmacy, Therapeutics, and Diagnostics Committee Reference: Safety SOP - Pneumatic Tube System Do Not Tube List for Pharmaceuticals (Revised April 2021) 1=Drug Alteration 2=Expense 3=Flammable 4= Product Foaming 5=Short Exp/Admin Time 6=ok to tube powder, but not the reconstituted product 7=Aerosol Containers over 2.5 ounces in volume 8=hazardous, antineoplastic 9=hazardous, non-antineoplastic, liquid and parenteral dosage forms (ok to tube solids) Generic Drug Name Brand Name(s) Comments DOXOrubicin Adriamycin 8 DOXOrubicin, liposomal Doxil; Lipodox 2, 8 Durvalumab Imfinzi 1 E F Eculizumab Soliris 2 Enasidenib Idhifa 8 Enfortunmab vedotin Padcev 1, 2, 8 Entrectinib Rozlytrek 8 Enzalutamide Xtandi 8 EpiRUBicin Ellence 8 Epoetin Epogen, Procrit, Retacrit 1 Epoprostenol Flolan, Veletri 1 Eptifibatide Integrelin 1 Eptinezumab-jjmr Vyepti 1, 2 Erdafitinib Balversa 8 EriBULin Halaven 8 Erlotinib Tarceva 8 Estradiol All Trade Names 9 Estramustine Emcyt, Estracyt 8 Estrogens All Trade Names 9 Etanercept Enbrel 1, 6 Ethacrynate injection Edecrin I.V. 2 Etoposide Toposar; VP 16 8 Etoposide phosphate Etopophos 8 Everolimus Afinitor 8 Exemestane Aromasin 8 Exenatide Bydureon, Byetta 9 Factor products All Factor Products 1, 2 Fam-trastuzumab deruxtecan-nxki Enhertu 1, 2, 8 Fat emulsions Intralipid, Liposyn, Omegaven 1 Fedratinib Inrebic 8 Fibrinogen concentrate (human) Fibryga 1 Filgrastim Granix, Neupogen, Zarxio 1 Floxuridine FUDR 8 Fluconazole Diflucan 9 Fludarabine Fludara 8 Fluocinolone intraocular implant Retisert 2 Fluorouracil Carac, Fluoroplex, Fluorouracil (5-FU), 8 Efudex, Tolak Flutamide Eulexin 8 Formaldehyde Formalin 3, 9 Approved by Pharmacy, Therapeutics, and Diagnostics Committee Reference: Safety SOP - Pneumatic Tube System Do Not Tube List for Pharmaceuticals (Revised April 2021) 1=Drug Alteration 2=Expense 3=Flammable 4= Product Foaming 5=Short Exp/Admin Time 6=ok to tube powder, but not the reconstituted product 7=Aerosol Containers over 2.5 ounces in volume 8=hazardous, antineoplastic 9=hazardous, non-antineoplastic, liquid and parenteral dosage forms (ok to tube solids) Generic Drug Name Brand Name(s) Comments Fosphenytoin Cerebyx 9 Fostamatinib Tavalisse 8 Fulvestrant Faslodex 8 G H Gallium nitrate Ganite 2 Galsulfase Naglazyme 1 GANciclovir Cytovene 9 Ganciclovir ocular implant Vitrasert 2 Gefitinib Iressa 8 Gemcitabine Gemzar, Infugem 8 Gemtuzumab ozogamicin Mylotarg 1, 2, 8 Gilteritinib Xospata 8 Givosiran Givlaari 2 Glatiramer Copaxone 1 Glucagon infusion Glucagon Infusion 2 Golimumab Simponi Aria 1 Gonadotropin, chorionic Novarel, Pregnyl 9 Goserelin zoladex 8 Hepatitis b immune globulin BayHep B, HyperHEP B, Nabi-HB 1, 4 Herpes zoster vaccine Shingrix, Zostavax 6 Histrelin implant kit Supprelin LA, Vantas 2, 8 Hydrochloric acid (2N concentrated solution; hydrochloric acid 9 diluted 0.1N, 1.5N, or 0.2N solution; Bernstein test for NG use) HYDROXYprogesterone caproate Makena 2 Hydroxyurea Droxia, Hydrea, Siklos 8 I L Ibrutinib Imbruvica 8 IDArubicin HCL IDArubicin HCL 8 Idursulfase Elaprase 2 Ifosfamide Ifex 8 Imatinib mesylate Gleevec 8 Imiglucerase Cerezyme 2 Immune globulin products Carimune, Flebogamma DIF, Gamimune, 2, 4 Gammagard, Gamunex-C InFLIXimab Remicade 1, 6 Inotuzumab ozogamicin Besponsa 1, 2, 8 Interferon alfa-2b Intron A 1, 6 Ipilimumab Yervoy 2 Irinotecan Camptosar, Onivyde 8 Isatuximab-irfc Sarclisa 1, 2, 8 Ivabradine Corlanor 9 Approved by Pharmacy, Therapeutics, and Diagnostics Committee Reference: Safety SOP - Pneumatic Tube System Do Not Tube List for Pharmaceuticals (Revised April 2021) 1=Drug Alteration 2=Expense 3=Flammable 4= Product Foaming 5=Short Exp/Admin Time 6=ok to tube powder, but not the reconstituted product 7=Aerosol Containers over 2.5 ounces in volume 8=hazardous, antineoplastic 9=hazardous, non-antineoplastic, liquid and parenteral dosage forms (ok to tube solids) Generic Drug Name Brand Name(s) Comments Ivosidenib Tibsovo 8 Ixabepilone Ixempra 2, 8 Ixazomib Ninlaro 8 Lanreotide Somatuline Depot 2 Lapatinib Tykerb 8 Laronidase Aldurazyme 1 Larotrectinib Vitrakvi 8 Lenvatinib Lenvima 8 Letermovir Prevymis 1 Letrozole Femara, Kisqali 8 Leuprolide Eligard, Fensolvi, Lupaneta, Lupron 2, 8 Liraglutide recombinant Victoza 9 Lomustine Gleostine 8 Lurbinectedin Zepzelca 2, 8 Luspatercept-aamt Reblozyl 1, 2, 9 M N Magnesium citrate Citrate of Magnesium 4 Margetuximab Margenza 1, 8 Measles, mumps,